{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"combined-immunodeficiency-due-to-ctps1-deficiency","columns":[{"gene":"","key":"population-8e90f8728b802210f9af","label":"Immunodeficiency 24","mondoId":"MONDO:0014391","onsetQualifier":null,"originColumnKey":"MONDO:0014391/OMIM:615897","originalViews":[{"key":"MONDO:0014391/OMIM:615897","label":"Immunodeficiency 24","scopeLabel":"OMIM:615897","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["018dcf4f008ccece6de813d1ccb68e8396027217bbb11a6fa42763c866e537b7","3f7b7d45e6f797ce1133df57580c0043227cba24f1b316c7838bb69dfd467e0c","55a157f517fa67988751110e80e04ee87c9f029ed151e5e94da65222ed0ccb63","5f28862ca76fb338c4e7f572eafe9588788095a86c27d6075a9ce57faccf6e64","71c65fc2a020da4357be19eb055358bfc91cded18cedd6603671193117ff1ec2","79d7202088e032dd16daa087cfce18f3421c2714d872f2f08f3ca43572ecc203","97eb3d058092a8b80cedcb23d28e7b3ecc18dc16b69f45a1584f5b9189629fd2","99c9e40a470b7cd40b02f002adfa5159b9ad69e4063d2a2f6868d11653bacb5b","a64840cdcf4f57680250a8b51477229a55aba72976270715bb4bda3f4c02539f","a6b897d3950a8774756d471a3988145134d83697f14837734f6eb8875e02a845","b688ccda3a8a84c896967072aaa9778031c352d8973c0e3fca55047a69b4e469","ba8db68a1e8c325c03ac0f8f01b1fc2570ef20a4de5cefacfad975e60dc78242","bdc82baa632e587650929871780aa90cbc1f3f8ce21168fcb1b7343e36b111a0","c1e2e1111ef784fec8dedeffaf86df0909e9c4f7da9a62af991b2958deac790e","ca12369a8073164e4befa5f13adad458f1046f958191ece5f122db4bfd7fd338","cd94813bee149bb645a387b429a0982dadf953a964129382280a41a0251981b2","f60f40a73ace01400a842524d431abdd999222856485c9c140f135ff7942c5c9"],"recordQualifiers":{},"scopeLabel":"OMIM:615897","sourceIds":["OMIM:615897"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-8e90f8728b802210f9af"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0031379","HP:0031402","HP:0004315","HP:0008348","HP:0012476","HP:0030374","HP:4000039"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":14,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":17,"sourceGroups":{"published":17}},"features":[{"hpoId":"HP:0031379","label":"Abnormal T cell proliferation","primary":true},{"hpoId":"HP:0031402","label":"Decreased antigen-specific T cell proliferation","primary":true},{"hpoId":"HP:0004315","label":"Decreased circulating IgG concentration","primary":true},{"hpoId":"HP:0008348","label":"Decreased circulating IgG2 concentration","primary":true},{"hpoId":"HP:0012476","label":"Decreased circulating specific pneumococcal antibody concentration","primary":true},{"hpoId":"HP:0030374","label":"Decreased memory B cell proportion","primary":true},{"hpoId":"HP:4000039","label":"Decreased mucosal-associated invariant T cell proportion","primary":true},{"hpoId":"HP:0001888","label":"Decreased total lymphocyte count","primary":false},{"hpoId":"HP:0002721","label":"Immunodeficiency","primary":false},{"hpoId":"HP:0033222","label":"Inverted CD4:CD8 ratio","primary":false},{"hpoId":"HP:0005523","label":"Lymphoproliferative disorder","primary":false},{"hpoId":"HP:0410297","label":"Partial absence of specific antibody response to tetanus vaccine","primary":false},{"hpoId":"HP:0032248","label":"Persistent viremia","primary":false},{"hpoId":"HP:0004429","label":"Recurrent viral infections","primary":false},{"hpoId":"HP:0011947","label":"Respiratory tract infection","primary":false},{"hpoId":"HP:0032170","label":"Severe varicella zoster infection","primary":false},{"hpoId":"HP:0031691","label":"Severe viral infection","primary":false}],"ledeHtml":"A rare primary immunodeficiency disorder due to impaired capacity of activated T- and B-cells to proliferate in response to antigen receptor-mediated activation characterized by early-onset, severe, persistent and/or recurrent viral infections due to Epstein-Barr virus (EBV) and Varicella Zoster virus (VZV, including generalized varicella), as well as recurrent sino-pulmonary bacterial infections due to encapsulated pathogens.","mondoId":"MONDO:0014391","node":{"canonicalSlug":"combined-immunodeficiency-due-to-ctps1-deficiency","comparisons":[{"documentSha256":"2a3b74570053a069b7dc44491b8fd11d8ef0bd308c63202b9f19332665886ce4","key":"legacy-combined-immunodeficiency-due-to-ctps1-deficiency","kind":"legacy","label":"combined immunodeficiency due to CTPS1 deficiency","memberIds":["MONDO:0014391"],"mondoId":"MONDO:0014391","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/combined-immunodeficiency-due-to-ctps1-deficiency.2a3b74570053a069b7dc44491b8fd11d8ef0bd308c63202b9f19332665886ce4.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Combined immunodeficiency due to CTPS1 deficiency","originalSourceId":"ORPHA:420573","paragraphs":["A rare primary immunodeficiency disorder due to impaired capacity of activated T- and B-cells to proliferate in response to antigen receptor-mediated activation characterized by early-onset, severe, persistent and/or recurrent viral infections due to Epstein-Barr virus (EBV) and Varicella Zoster virus (VZV, including generalized varicella), as well as recurrent sino-pulmonary bacterial infections due to encapsulated pathogens."],"rawAttribution":"MONDO:0014391","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:02:46Z","upstream":"MONDO:0014391","url":"https://rarediseases.info.nih.gov/diseases/17696"},"ownColumnKeys":["population-8e90f8728b802210f9af"],"publication":"published","relationships":[{"kind":"parent","label":"combined immunodeficiency","mondoId":"MONDO:0015131","slug":"combined-immunodeficiency"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"018dcf4f008ccece6de813d1ccb68e8396027217bbb11a6fa42763c866e537b7","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":"1/5","hpo_id":"HP:0032248","is_excluded":false,"label":"Persistent viremia","onset_id":null,"reference":"PMID:32161190","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3f7b7d45e6f797ce1133df57580c0043227cba24f1b316c7838bb69dfd467e0c","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":"8/8","hpo_id":"HP:0004429","is_excluded":false,"label":"Recurrent viral infections","onset_id":null,"reference":"PMID:24870241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"55a157f517fa67988751110e80e04ee87c9f029ed151e5e94da65222ed0ccb63","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002721","is_excluded":false,"label":"Immunodeficiency","onset_id":null,"reference":"PMID:32161190","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"5f28862ca76fb338c4e7f572eafe9588788095a86c27d6075a9ce57faccf6e64","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0008348","is_excluded":false,"label":"Decreased circulating IgG2 concentration","onset_id":null,"reference":"PMID:24870241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"71c65fc2a020da4357be19eb055358bfc91cded18cedd6603671193117ff1ec2","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0012476","is_excluded":false,"label":"Decreased circulating specific pneumococcal antibody concentration","onset_id":null,"reference":"PMID:32161190","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"79d7202088e032dd16daa087cfce18f3421c2714d872f2f08f3ca43572ecc203","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001888","is_excluded":false,"label":"Decreased total lymphocyte count","onset_id":null,"reference":"PMID:24870241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"97eb3d058092a8b80cedcb23d28e7b3ecc18dc16b69f45a1584f5b9189629fd2","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":"4/5","hpo_id":"HP:0004315","is_excluded":false,"label":"Decreased circulating IgG concentration","onset_id":null,"reference":"PMID:32161190","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"99c9e40a470b7cd40b02f002adfa5159b9ad69e4063d2a2f6868d11653bacb5b","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":"3/5","hpo_id":"HP:0011947","is_excluded":false,"label":"Respiratory tract infection","onset_id":null,"reference":"PMID:32161190","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"a64840cdcf4f57680250a8b51477229a55aba72976270715bb4bda3f4c02539f","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0031691","is_excluded":false,"label":"Severe viral infection","onset_id":null,"reference":"PMID:24870241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a6b897d3950a8774756d471a3988145134d83697f14837734f6eb8875e02a845","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0030374","is_excluded":false,"label":"Decreased memory B cell proportion","onset_id":null,"reference":"PMID:32161190","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b688ccda3a8a84c896967072aaa9778031c352d8973c0e3fca55047a69b4e469","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":"3/5","hpo_id":"HP:0032170","is_excluded":false,"label":"Severe varicella zoster infection","onset_id":null,"reference":"PMID:32161190","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ba8db68a1e8c325c03ac0f8f01b1fc2570ef20a4de5cefacfad975e60dc78242","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0031379","is_excluded":false,"label":"Abnormal T cell proliferation","onset_id":null,"reference":"PMID:24870241","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"bdc82baa632e587650929871780aa90cbc1f3f8ce21168fcb1b7343e36b111a0","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:4000039","is_excluded":false,"label":"Decreased mucosal-associated invariant T cell proportion","onset_id":null,"reference":"PMID:32161190","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c1e2e1111ef784fec8dedeffaf86df0909e9c4f7da9a62af991b2958deac790e","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0031402","is_excluded":false,"label":"Decreased antigen-specific T cell proliferation","onset_id":null,"reference":"PMID:32161190","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ca12369a8073164e4befa5f13adad458f1046f958191ece5f122db4bfd7fd338","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":"1/5","hpo_id":"HP:0005523","is_excluded":false,"label":"Lymphoproliferative disorder","onset_id":null,"reference":"PMID:32161190","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cd94813bee149bb645a387b429a0982dadf953a964129382280a41a0251981b2","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":"3/4","hpo_id":"HP:0410297","is_excluded":false,"label":"Partial absence of specific antibody response to tetanus vaccine","onset_id":null,"reference":"PMID:32161190","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f60f40a73ace01400a842524d431abdd999222856485c9c140f135ff7942c5c9","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:615897","disease_name":"Immunodeficiency 24","evidence":"PCS","frequency_raw":"2/5","hpo_id":"HP:0033222","is_excluded":false,"label":"Inverted CD4:CD8 ratio","onset_id":null,"reference":"PMID:32161190","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17696\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014391\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0014391</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare primary immunodeficiency disorder due to impaired capacity of activated T- and B-cells to proliferate in response to antigen receptor-mediated activation characterized by early-onset, severe, persistent and/or recurrent viral infections due to Epstein-Barr virus (EBV) and Varicella Zoster virus (VZV, including generalized varicella), as well as recurrent sino-pulmonary bacterial infections due to encapsulated pathogens.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17696\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"combined-immunodeficiency-due-to-ctps1-deficiency","sourceDocuments":[{"name":"GARD: Combined immunodeficiency due to CTPS1 deficiency","reviewed":null,"source_release":"2026-10-21T17:02:46Z","url":"https://rarediseases.info.nih.gov/diseases/17696"},{"name":"MONDO: combined immunodeficiency due to CTPS1 deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014391"}],"sourceNote":"","synonyms":["CTPS1-related combined immunodeficiency","IMD24","immunodeficiency 24","immunodeficiency type 24","SCID due to CTPS1 deficiency"],"takeawayHtml":"","title":"combined immunodeficiency due to CTPS1 deficiency"},"schemaVersion":1}
